The trial commences on 2 October 2028, and is scheduled to last for ten weeks. 

On this date, the parties must file and exchange their trial skeletons. 

During this week, the pre-trial review hearing will be held.

On this date, and following meetings to take place by 7 June 2028, the parties’ experts in each field must produce a joint statement on matters agreed and not agreed. 

On this date, the Class Representative must file and serve her expert accounting and competition economics reports in reply (i.e., those responding to Meta’s expert reports)

On this date, Meta must file and serve its expert accounting and competition economics reports.

On this date, the Class Representative must file and serve her expert accounting and competition economics reports.

On this date, the parties must file and exchange any factual witness statements in response to those served on 27 October 2027.

On this date, the parties must file and exchange the factual witness statements they wish to rely on at trial.

If required (i.e. in response to any Re-Amended Defence), Dr Gormsen must file a Re-Amended Reply by this date.

If required (i.e in response to any Re-Re-Amended Claim Form), Meta must file a Re-Amended Defence by this date.

During this week, the Tribunal will hold a hearing to decide any application, to amend and any outstanding applications for further disclosure.

By this date, Dr Lovdahl Gormsen will either file and serve her Re-Re-Amended Claim Form (if Meta consents to all of the amendments) or file an application for permission to amend if the amendments are contested.

By this date, Meta must confirm whether they consent to or oppose the amendments the Class Representative is to provide on 26 May 2027. 

By this date, the Class Representative must make any applications for Meta to provide additional disclosure.

By this date the Class Representative must provide a draft of her amended pleadings, taking account of the disclosure Meta will have provided by 10 February 2027. She must also, by this date, answer a Request for Information from Meta as regards the data falling within her claim. 

Meta must complete its disclosure of documents by this date.

On this date, the Court of Appeal heard Meta’s application for permission to appeal the Tribunal granting permission for the Class Representative to seek user damages from Meta. The Court of Appeal refused all grounds of Meta’s application. Their judgment can be read here.

On this date, the Tribunal held a hearing to determine the directions to trial. Their Ruling, and the Order arising from this hearing, can be found here.

On this date, the Tribunal held a hearing to determine the final outstanding issues between the Class Representative and Meta as regards disclosure, as well as other outstanding applications. Their Ruling, and the Order arising from this hearing, can be found here.

On this date, the Tribunal held a hearing to determine certain issues as regards what disclosure Meta needs to provide to the Class Representative. Their Ruling, and the Order arising from this hearing, can be found here.

On 24 - 26 November 2025, there was a hearing to determine what disclosure Meta will need to provide to the Class Representative (i.e., data, documents and communications). Their Ruling, and the Order arising from this hearing, can be found here.

On this date, there was a hearing to determine whether to accept Dr Gormsen’s amendments to the case to introduce the remedy of “user damages”, which would serve as a different legal basis to seek compensation from Meta. The Tribunal granted Dr Gormsen permission to amend at this hearing, and ordered Meta to pay her costs of the application relating to their opposition. The Tribunal’s Ruling can be read here.

On this date, there was a hearing to determine the next steps in the case on disclosure.

The deadline to opt out has now passed, pursuant to the Tribunal’s Order dated 2 May 2024.

On 5 December 2024, Dr Lovdahl Gormsen, published a notice setting out details of her claim and the procedure for opting out of it. This notice can be viewed here.

On this date, the Court of Appeal refused to grant Meta permission to appeal the Tribunal's judgment certifying the claim.

The Tribunal on the 2 May 2024 made a Collective Proceedings Order, certifying the Claim and authorising Dr Lovdahl Gormsen as the Class Representative.  

The Competition Appeal Tribunal released its judgment certifying the claim, paving the way for a full trial of Dr Lovdahl Gormsen's case.  

Next Steps

The parties are currently liaising as to the next procedural steps in the claim and the directions to trial. We will keep this website updated as the case progresses.

The CPO Application was heard by the Competition Appeal Tribunal for two days from 8-9 January 2024.

Dr. Liza is to file and serve any reply to the response filed and served by the Meta Defendants on 13 December 2023.

Dr. Liza Lovdahl Gormsen published the Notice of the CPO Application Hearing, following the listing of the CPO Application hearing for 8-9 January 2024. The Notice, which can be found here sets out key information for potential class members, and should be read carefully. Such information includes how to object to Dr. Liza’s application for a collective proceedings order and/or to act as class representative (which was to be done by no later than 4pm on 6 December 2023), and how to apply to the Tribunal for permission to make oral and/or written submissions at the hearing (which was also to be done by no later than 4pm on 6 December 2023).

The Meta Defendants filed and served their response to Dr. Liza’s revised application for a CPO.

As per the attached notice, 4pm on 6 December 2023 was the deadline if you wished to (i) object to Dr Liza’s application for a Collective Proceedings Order, and/or her application to act as class representative in these proceedings (ii) apply to the Tribunal for permission to make oral and/or written submissions at the hearing.

On this date, the Proposed Class Representative filed additional evidence for her application. 

The judgment of the Tribunal on the CPO Application was released on 20 February 2023, and can be read here.

The CPO Application was heard by the Competition Appeal Tribunal for three days from 30 January to 1 February 2023.

The Competition Appeal Tribunal informed the parties on this date that the CMC listed for 26 September would no longer take place, after the parties’ agreed there were no outstanding issues to address at it.

The Competition Appeal Tribunal informed the parties on this date that a case management conference was to be held on 26 September, and that the Tribunal that will be hearing the case has been appointed.

With these acknowledgments of service came confirmation they do not intend to challenge jurisdiction, paving the way for the next step in proceedings - scheduling a case management conference.

Following the Tribunal granting permission, these Proposed Defendants were served in the United States and the Republic of Ireland, respectively.

Following the Judgment an Order of the Tribunal was made on 22 March 2023, providing six months for the Proposed Class Representative to file revised evidence.

By order of Sir Marcus Smith, President of the Competition Appeal Tribunal, Dr. Liza Lovdahl Gormsen’s application to serve Meta Platforms Inc in the United States, and Meta Platforms Ireland Limited in the Republic of Ireland, was granted. The Order can be read here.

This summary sets out details of Dr. Liza Lovdahl Gormsen’s proposed collective proceedings, including details on the Proposed Defendants, Facebook’s alleged dominant position and abuse, the proposed class members, and the case for certifying the collective proceedings. The summary can be read here.

Dr. Liza Lovdahl Gormsen’s solicitors served Facebook UK with a copy of the claim form at their offices.

Dr. Liza Lovdahl Gormsen filed her claim against Facebook UK Limited, Meta Platforms Ireland Limited and Meta Platforms Inc with the Competition Appeal Tribunal on behalf of 44 million UK Facebook Users.

This date marks the end of the claim period of Dr. Liza Lovdahl Gormsen’s claim.